CHEN ISAN 4
4 · Mirati Therapeutics, Inc. · Filed Jan 25, 2019
Insider Transaction Report
Form 4
CHEN ISAN
Chief Medical & Dev't Officer
Transactions
- Exercise/Conversion
Common Stock
2019-01-23$24.99/sh+244$6,098→ 35,210 total - Exercise/Conversion
Common Stock
2019-01-23$21.51/sh+625$13,444→ 35,835 total - Exercise/Conversion
Common Stock
2019-01-23$5.40/sh+1$5→ 35,836 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-01-23−625→ 25,283 totalExercise: $21.51Exp: 2025-02-03→ Common Stock (625 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-01-23−1→ 49,997 totalExercise: $5.40Exp: 2027-01-25→ Common Stock (1 underlying) - Exercise/Conversion
Stock Options
2019-01-23−244→ 59,756 totalExercise: $24.99Exp: 2026-01-21→ Common Stock (244 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.